Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 1/20 | 0.35 |
| ▸ | RXRG | P48443 | 1/20 | 0.35 |
| ▸ | KIF11 | P52732 | 1/20 | 0.35 |
| ▸ | TACR1 | P25103 | 2/20 | 0.34 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.33 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.33 |
| ▸ | ICMT | O60725 | 2/20 | 0.33 |
| ▸ | ELANE | P08246 | 3/20 | 0.32 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.32 |
| ▸ | PGR | P06401 | 1/20 | 0.31 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24369941 | 0.95 | RXRA (0.36) | RXRARXRGKIF11TACR1PTGER4 | |
| SCHEMBL24369975 | 0.94 | RXRA (0.32) | RXRARXRGKIF11TACR1PTGER4 | |
| SCHEMBL24369787 | 0.94 | PGR (0.34) | RXRARXRGKIF11TACR1PTGER4 | |
| SCHEMBL24370441 | 0.94 | ELANE (0.33) | RXRARXRGKIF11TACR1PTGER4 | |
| SCHEMBL24370118 | 0.93 | ELANE (0.38) | RXRARXRGKIF11TACR1PTGER4 | |
| SCHEMBL24370061 | 0.93 | KIF11 (0.31) | RXRARXRGKIF11TACR1PTGER4 | |
| SCHEMBL24370188 | 0.93 | ALOX5AP (0.33) | RXRARXRGKIF11TACR1PTGER4 | |
| SCHEMBL20849277 | 0.93 | KIF11 (0.37) | RXRARXRGKIF11TACR1PTGER4 | |
| SCHEMBL20849579 | 0.92 | RXRA (0.35) | RXRARXRGKIF11TACR1PTGER4 | |
| SCHEMBL24370207 | 0.91 | PTGER4 (0.33) | RXRARXRGTACR1PTGER4PDPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220131080-A1 | CARBAZOLE DERIVATES FOR USE IN OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220131080-A1 | CARBAZOLE DERIVATES FOR USE IN OPTOELECTRONIC DEVICES | SIK3, ORAI3, HIPK3 | RXRA 4688/4885RXRG 4524/4885KIF11 3200/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.